Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Mar 14, 2024 (filed on Mar 15, 2024)Insider Name:Spoerel Thomas JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-282Price:$238.29
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Garrison Michael DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-178Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Spoerel Thomas JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-36Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Ezell Antoine COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-282Price:--
-
Feb 05, 2024 (filed on Feb 07, 2024)Insider Name:Jones Christopher Ian MontagueOwnership Type:Direct OwnershipSecurities:Rights to Common Stock Under BD Deferred Compensation PlanNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:126Price:$238.80
-
Feb 05, 2024 (filed on Feb 07, 2024)Insider Name:Byington Carrie LOwnership Type:Direct OwnershipSecurities:Rights to Common Stock Under BD Deferred Compensation PlanNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:126Price:$238.80
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Waldstreicher JoanneOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Scott Bertram LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Ring Timothy MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Jones Christopher Ian MontagueOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
Filings by filing date
-
Mar 14, 2024 (filed on Mar 15, 2024)Insider Name:Spoerel Thomas JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-282Price:$238.29
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Garrison Michael DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-178Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Spoerel Thomas JOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-36Price:--
-
Mar 01, 2024 (filed on Mar 05, 2024)Insider Name:Ezell Antoine COwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-282Price:--
-
Feb 05, 2024 (filed on Feb 07, 2024)Insider Name:Jones Christopher Ian MontagueOwnership Type:Direct OwnershipSecurities:Rights to Common Stock Under BD Deferred Compensation PlanNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:126Price:$238.80
-
Feb 05, 2024 (filed on Feb 07, 2024)Insider Name:Byington Carrie LOwnership Type:Direct OwnershipSecurities:Rights to Common Stock Under BD Deferred Compensation PlanNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:126Price:$238.80
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Waldstreicher JoanneOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Scott Bertram LOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Ring Timothy MOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
-
Jan 23, 2024 (filed on Jan 25, 2024)Insider Name:Jones Christopher Ian MontagueOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:900Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | One Becton Drive FRANKLIN LAKES NJ 07417-1880 |
Tel: | N/A |
Website: | https://www.bd.com |
IR: | See website |
Key People | ||
Thomas E. Polen Chairman of the Board, President, Chief Executive Officer | Pavan Mocherla Executive Vice President, President, Greater Asia | Christopher DelOrefice Chief Financial Officer, Executive Vice President |
David B. Hickey Executive Vice President, President - Life Sciences Segment | Shana Carol Neal Chief People Officer, Executive Vice President | Antoine C. Ezell Executive Vice President, President, North America, Chief Marketing Officer |
Michelle Quinn Executive Vice President, General Counsel | Richard Byrd Executive Vice President, President - Interventional Segment | Michael Garrison Executive Vice President, President - Medical Segment | Roland Goette Executive Vice President, President - EMEA |
Business Overview |
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. The Company's BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a wide range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, and pharmaceutical systems. The Company's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Interventional segment provides vascular, urology, oncology and surgical specialty products. |
Financial Overview |
For the three months ended 31 December 2023, Becton Dickinson and Co revenues increased 3% to $4.71B. Net income applicable to common stockholders decreased 42% to $281M. Revenues reflect Medical segment increase of 4% to $2.23B, Interventional segment increase of 5% to $1.19B, United States segment increase of 1% to $2.75B. Net income was offset by Restructuring costs increase from $26M to $69M (expense). |
Employees: | 73,000 as of Sep 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $86,417M as of Dec 31, 2023 |
Annual revenue (TTM): | $19,492M as of Dec 31, 2023 |
EBITDA (TTM): | $4,758M as of Dec 31, 2023 |
Net annual income (TTM): | $1,265M as of Dec 31, 2023 |
Free cash flow (TTM): | $1,541M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $14,928M as of Dec 31, 2023 |
Shares outstanding: | 288,902,232 as of Dec 31, 2023 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |